Most organisms use endogenous timekeeping mechanisms to coordinate their physiology with the external cycle of day and night. These circadian rhythms have a cell-autonomous basis ([@bibr3-0748730419836370]; [@bibr53-0748730419836370]) orchestrating many cellular functions, such as DNA repair, protein synthesis, and cell division, to an approximately 24-h beat ([@bibr11-0748730419836370]; [@bibr24-0748730419836370]; [@bibr28-0748730419836370]; [@bibr29-0748730419836370]). Circadian rhythms bestow a selective advantage upon organisms in rhythmic and arrhythmic settings by synchronising them with predictable daily environmental cycles and facilitating the temporal segregation of mutually antagonistic processes ([@bibr4-0748730419836370]; [@bibr52-0748730419836370]). In most cell types, these temporal programs are thought to be dependent on the rhythmic regulation of gene expression by oscillating "clock gene" activity, in turn facilitated by transcriptional feedback repression of clock gene transcription by their own protein products ([@bibr44-0748730419836370]).

Transcriptional oscillations are not essential for circadian rhythms; bona fide circadian rhythms occur in the complete absence of transcription in the alga *Ostreococcus tauri* ([@bibr37-0748730419836370]), in human red blood cells (RBCs) ([@bibr36-0748730419836370]), and in other organisms ([@bibr25-0748730419836370]; [@bibr46-0748730419836370]; [@bibr55-0748730419836370]). Importantly, these examples of transcription-independent circadian rhythms satisfy the 3 fundamental properties that define circadian clocks ([@bibr39-0748730419836370]): they are entrained by relevant environmental cues, such as light or temperature; they free run with an approximately 24-h period; and they are temperature compensated, meaning that they do not run faster at higher temperatures, i.e., Q~10~ ≈ 1, unlike most chemical and biochemical reactions, where Q~10~ ≈ 2.

Although temperature compensation is a defining feature of circadian clocks, it remains poorly understood. Some period-determining processes, and thus candidate mechanisms that facilitate temperature compensation, are known, and these tend to involve the phosphorylation of clock proteins by Ser/Thr kinases ([@bibr16-0748730419836370]). One important and evolutionarily conserved post-translational modifier is casein kinase 1 (CK1), which phosphorylates non-orthologous clock protein targets, such as PERIOD (PER) in mammals and FREQUENCY (FRQ) in fungi ([@bibr19-0748730419836370]; [@bibr31-0748730419836370]), and has been shown to regulate period and temperature compensation of circadian rhythms across eukaryotes ([@bibr7-0748730419836370]; [@bibr19-0748730419836370]; [@bibr22-0748730419836370]; [@bibr31-0748730419836370]; [@bibr51-0748730419836370]).

Whilst mutation of individual PERIOD homologs can alter circadian period by several hours, these perturbations have only modest effects on temperature compensation ([@bibr12-0748730419836370]). Recently, it was shown that CK1δ/ε-dependent phosphorylation is intrinsically temperature compensated, with a CK1-specific domain around K224 sufficient to confer temperature compensation on other kinases ([@bibr23-0748730419836370]; [@bibr43-0748730419836370]). Since temperature compensation and the circadian function of CK1 exhibit far greater evolutionary conservation than any known clock protein substrate or clock gene transcriptional circuit, we hypothesised that the timekeeping and temperature compensation function of CK1 might extend beyond its known interaction with clock gene transcriptional circuits to include transcription-independent circadian rhythms. Here, we employed a reduced model of non-transcriptional circadian rhythms---isolated human RBCs---to test whether period determination and temperature compensation remain dependent on CK1 activity in the absence of clock protein expression and cycling transcription.

Materials and Methods {#section1-0748730419836370}
=====================

Experimental Model and Subject Details {#section2-0748730419836370}
--------------------------------------

Studies were conducted in accordance with the principles of the Declaration of Helsinki, with approval/favourable opinion from our local Research Ethics Committee. Participants in the study were screened for relevant self-reported health issues, including sleep disorders or excessive daytime sleepiness. All participants provided written, informed consent after having received a detailed explanation of the study procedures. RBCs were isolated from male participants, with RBCs from 4 separate donors for each treatment or experimental condition.

Human RBC Isolation {#section3-0748730419836370}
-------------------

RBCs were isolated following the protocol of [@bibr20-0748730419836370]. RBCs were isolated from anticoagulant-treated whole blood (lithium heparin Vacutainer, BD Biosciences; Franklin Lakes, NJ) by density gradient centrifugation, layering a mixture (1:2.67) of whole blood and Dulbecco's phosphate-buffered saline (DPBS; Sigma-Aldrich, St Louis, MO) on top of Histopaque-1077 (Sigma-Aldrich) at 50 ×*g* for 30 min. RBCs were washed once in DPBS (250 ×*g* for 15 min) and once in modified Krebs-Henseleit buffer (KHB; Sigma-Aldrich) (250 ×*g* for 10 min). KHB was modified by supplementation with calcium chloride dihydrate (to a final concentration of 2.54 mM), sodium bicarbonate (25 mM), bovine serum albumin (1 g/l), penicillin (100 U/l ) and streptomycin (100 µg/l), and adjusted to pH 7.4 and 290-299 mOsm. After washing, 330 µl of packed RBCs were added to 40 ml of KHB.

Circadian Entrainment {#section4-0748730419836370}
---------------------

RBCs were subjected to daily temperature cycles (12 h, 37°C; 12 h, 32°C) for 2 days using a programmed thermal cycler before transfer into constant temperature conditions of either 37°C or 32°C (as specified). Samples were taken at 3- or 4-hourly intervals upon transfer into constant conditions, with a single 500-µl PCR tube of RBCs at each time point for each donor. Following convention, the transition to constant conditions was taken as *t* = 0.

Dielectrophoresis {#section5-0748730419836370}
-----------------

After the 48-h entrainment, at each timepoint, a single PCR tube was removed from the thermal cycler to assess cell electrophysiology by dielectrophoresis (DEP). The modified KHB medium was removed and the pellet was suspended in iso-osmotic DEP medium (248 mM sucrose, 16.7 mM dextrose, 250 mM MgCl~2~, 100 mM CaCl~2~, adjusted to 290-299 mOsm and a conductivity of 0.043 S/m using DPBS). Cells in DEP medium were then centrifuged for 2 min at 500 ×*g*, and the medium was replaced with fresh DEP medium to reduce ionic carryover from the high ionic strength of the KHB medium. The cells were subsequently adjusted to a final concentration of 10^6^ per ml and pipetted into 3DEP chips (Labtech; Heathfield, East Sussex, UK). Chips were analysed by a 3DEP 3D Dielectrophoresis Cell Analysis System (3DEP reader, Labtech). The wells were energised for 30 s at 10 Vp--p, at 20 frequencies between 10 kHz and 20 MHz. This was repeated 3 to 4 times for each donor at each time point. The raw data were fitted with a single-shell model using 3DEP software (v1.2, Labtech, <https://www.labtech.com/3dep-3d-dielectrophoresis-cell-analysis-system>) to extract the electrophysiological parameters; models that produced an R value (Pearson correlation coefficient) of 0.95 or lower were excluded.

Bioluminescence Imaging {#section6-0748730419836370}
-----------------------

Human U2OS cells (HTB-96, ATCC; Manassas, VA) were stably transfected with *BMAL1:Luc* and cultured in Dulbecco's Modified Essential Medium (DMEM) supplemented with 10% HyClone FetalClone II Serum (Thermo Fisher Scientific; Waltham, MA), 1 mM luciferin (Biosynth AG; Staad, Switzerland), 100 U/mL penicillin, 100 μg/mL streptomycin, and 2 μg/mL puromycin (to maintain selection). Four days before bioluminescence imaging, cells were trypsinized, resuspended in culture medium, seeded into six 96-well white plates at a density of 10^4^ cells per well, and incubated in a humidified incubator for 96 h (37°C, 5% CO~2~) under daily applied temperature cycles (12 h 32°C; 12 h 37°C). At 4 h before the anticipated transition to the warm phase, cell media was exchanged for recording media (± drug or vehicle) and the plates were placed into an ALLIGATOR for bioluminescence imaging, and were maintained at a constant temperature and 5% CO~2~ ([@bibr10-0748730419836370]). The recording media was identical to the culture media except that the serum concentration was reduced to 1%; B27 supplement (Thermo Fisher) was added to a final concentration of 2%, and puromycin was omitted. For constant culture conditions at 40°C, cells were plated as above but, rather than being subjected to daily temperature cycles, incubation temperature was increased by 1°C per day from 37°C to 40°C to acclimate cells to the higher temperature. Cells were synchronised on the fourth day after plating, with the media changed to media containing B27, as described above. Bioluminescence levels were integrated every 30 min without EM gain.

Gel Electrophoresis and Immunoblotting {#section7-0748730419836370}
--------------------------------------

RBC pellets were lysed by trituration in 200 µl 1× LDS sample buffer (Thermo Fisher Scientific) supplemented with 10 mM TCEP. Before electrophoresis, samples were heated at 70°C for 10 min on a heat block. Western blotting and SDS-PAGE were performed using the NuPage Novex mini system (Thermo Fisher Scientific) with 4% to 12% bis-tris gradient gels and nitrocellulose transfer stacks, used according to the manufacturer's instructions. Blots were blocked in 5% (w/v) non-fat dried milk (Marvel) dissolved in Tris-buffered saline containing 0.05% Tween-20 (TBST) for 1 h at room temperature, and then incubated overnight at 4°C on a rotary shaker with primary antibodies diluted in blocking buffer. Primary antibodies were as follows: rabbit anti-CK1α (1:1000, ab108296; Abcam, Cambridge, UK), mouse anti-CK1δ (1:1000, ab85320; Abcam), mouse anti-CK1ε (1:2000, ab82426; Abcam), rabbit anti-CK2α' (1:1000, ab10474; Abcam) and rabbit anti-CK2β (1:1000, ab133576; Abcam). Blots were washed for 3 × 5 min in TBST then incubated for 1 h with HRP-conjugated anti-rabbit (1:5000) or anti-mouse (1:10,000) secondary antibodies. Blots were washed again for 3 × 15 min with TBST before chemiluminescence detection using Immobilon Western Chemiluminescent HRP Substrate (Millipore; Billerica, MA), according to manufacturer's instructions. RIPA extract lysates of U2OS cells transfected with mammalian expression constructs of V5-CK1α (Addgene plasmid \#92014, pCAGImC_V5-CSNK1A1, a gift from Joshua Mendell), CK1δ-V5His, HA-CK1ε (Addgene plasmid \#13724, V405 4HA-CKIe, a gift from David Virshup), HA-CK2α' and Myc-CK2β (Addgene plasmids \#27087 and \#27088, pZW16 \[CK2alpha'\] and pZW12 \[CK2beta\] respectively; gifts from David Litchfield) served as positive controls.

Pharmacological Treatments {#section8-0748730419836370}
--------------------------

For each drug, cell viability and morphology were initially screened over a period of 2 to 4 days using a range of concentrations. Concentrations of the drug that did not result in hemolysis or altered viability or morphology under our experimental conditions (following [@bibr20-0748730419836370]) were chosen for subsequent time-course experiments. The drugs used in this study---staurosporine, PF-670462, D4476 (all Sigma-Aldrich), and TTP22 (Tocris Biosciences; Bristol, UK)---were prepared in DMSO according to the manufacturer's instructions. Drugs were diluted in KHB and delivered as a 10X concentration bolus to RBC suspensions to achieve the final concentration. In each case, an equivalent % of DMSO was used as a vehicle control. Drugs were added to RBC suspensions at ZT0 on day 1 (staurosporine) or circadian time (CT)-0 on day 3 (PF-670462, D4476, TTP22), as indicated in the figure legend. For human U2OS cells, PF-670462 was diluted from a 10 mM DMSO stock directly into recording medium, and was delivered to cells through a media change at the beginning of the recording. This was compared with vehicle control (between 0.03% to 0.1% DMSO).

Sequence Comparisons {#section9-0748730419836370}
--------------------

The following sequences were compared: the catalytic domain (8-282) and C-terminus (283-end) of human CK1 delta isoform 1 (NP_001884), isoform 2 (NP_620693) and isoform 3 (NP_001350678); the catalytic domain (isoform 1: 16-309; isoforms 2 and 3: 16-281) and C-terminus (isoform 1: 309-end; isoforms 2 and 3: 282-end) of human CK1 alpha isoform 1 (NP_001020276), isoform 2 (NP_001883.4) and isoform 3 (NP_001258670.1). Orthologous sequences in *Arabidopsis thaliana* (NP_193170), *Neurospora crassa* (ESA44278), *Ostreococcus tauri* (OUS42226) and *Drosophila melanogaster* (CK1 alpha: CAA64358; doubletime/discs overgrown: NP_524602) were also compared using NCBI protein-protein Basic Local Alignment Search Tool (BLASTP) using default settings.

Quantification and Statistical Analysis {#section10-0748730419836370}
---------------------------------------

All data are presented as the mean ± SEM, where *n* refers to the number of biological replicates. To determine whether a circadian rhythm was present in time-course experiments, and subsequently the circadian parameters period, amplitude and phase, a damped cosine was fit to the data, as described by [@bibr21-0748730419836370], using least squares non-linear regression curve fitting in GraphPad Prism (v7.03, GraphPad; La Jolla, CA). Briefly, a straight line fit ($Y\left( X \right) = mX + c$) was compared with a damped cosine + baseline fit:

$$\begin{array}{l}
{Y\left( X \right) = mX + Baseline + Amplitude \times} \\
{e^{- kX} \times \cos\left( \frac{2\pi\left( {X - Phaseshift} \right)}{Period} \right)} \\
\end{array}$$

where *X* = time, using the extra sum-of-squares F comparison test in GraphPad Prism, with the simpler model being preferred unless the *p* value was \< 0.05. For the calculation of Q~10~ value, the period values were entered into the following equation:

$$Q_{10} = \left( \frac{\tau_{1}}{\tau_{2}} \right)^{\frac{10}{T_{2} - T_{1}}}$$

where τ~1~ and τ~2~ are the period at temperature T~1~ and T~2~, respectively. T~1~ = 32°C and T~2~ = 37°C. Rhythm parameters (i.e., period), derived from the best fit~cosinor~, were compared using the extra sum-of-squares F comparison test and 2-way ANOVA. If ANOVA revealed significant (*p* \< 0.05) effects, Holm-Sidak's multiple comparison post hoc tests were used to determine *p* values for all relevant comparisons. All analyses were performed in Graphpad Prism. Statistically significant differences were defined as those with a *p* value \< 0.05. The significance level is indicated as \**p* \< 0.05, \*\**p* \< 0.01 and \*\*\**p* \< 0.001.

Results {#section11-0748730419836370}
=======

We previously reported the circadian regulation of membrane electrophysiology and potassium transport in isolated human RBCs under constant conditions using an assay based on DEP ([@bibr20-0748730419836370]). Kinases fulfill essential timing functions in the circadian clocks of other mammalian cells (i.e., those with nuclei) and we were therefore interested in understanding whether this extended to encompass the transcription-independent circadian clock of RBCs. We used staurosporine, a broad-spectrum kinase inhibitor first shown to dramatically alter the free-running period in the dinoflagellate *Gonyaulax polyedra* ([@bibr9-0748730419836370]), as a proof-of-principle test of the hypothesis that kinases regulate the RBC circadian clock. Staurosporine treatment dramatically increased the period of rhythms in membrane conductance (*G*~eff~) and cytoplasmic conductivity (*σ*~cyt~) ([Fig. 1A-C](#fig1-0748730419836370){ref-type="fig"}), similar to its activity in nucleated cells ([@bibr9-0748730419836370]). RBCs are therefore an amenable platform with which to test kinase function in the RBC clockwork using small-molecule inhibitors.

![RBC circadian rhythms are affected by the inhibition of protein kinases. Isolated RBCs were cultured in the presence of 10 μM staurosporine (STS) or vehicle control at constant 37°C after 2 days of temperature entrainment. DEP measurements of membrane conductance (*G*~eff~) (A) and cytoplasmic conductivity (*σ*~cyt~) (B) are reported (mean ± SEM, *n* = 4). Damped cosine curves were fitted to the data using non-linear regression comparison of fits (H~1~ = damped cosine model, H~0~ = straight line) extra sum-of-squares F test. Cosine fit was preferred over straight line fit if *p* \< 0.05. *G*~eff~ and *σ*~cyt~ oscillate in antiphase, as previously reported ([@bibr20-0748730419836370]). (C) STS treatment significantly increases the period of both *G*~eff~ and *σ*~cyt~ rhythms relative to vehicle control (period values derived from best fit~cosinor~ ± SEM; *n* = 4. Two-way ANOVA *p* value (*p*~TWA~) and Holm-Sidak's post hoc tests reported).](10.1177_0748730419836370-fig1){#fig1-0748730419836370}

Casein kinases play functionally conserved roles in timekeeping across eukaryotes, with roles attributed to CK1 homologs (CK1α, CK1δ, CK1ε) and CK2 ([@bibr19-0748730419836370]; [@bibr22-0748730419836370]; [@bibr31-0748730419836370]; [@bibr51-0748730419836370]). RBCs express one CK1 paralogue, CK1α, as well as catalytic and regulatory subunits of CK2: CK2α', and CK2β ([Fig. 2A](#fig2-0748730419836370){ref-type="fig"} and [Supplementary Figure S1](https://journals.sagepub.com/doi/suppl/10.1177/0748730419836370)) ([@bibr6-0748730419836370]). Therefore, we explored whether their timekeeping role extended to non-transcriptional oscillations in RBCs by applying casein kinase inhibitors that are known to affect period determination in nucleated cells ([@bibr1-0748730419836370]; [@bibr32-0748730419836370]). We found that TTP22, an inhibitor of CK2 ([@bibr18-0748730419836370]), and D4476, an inhibitor of CK1 ([@bibr2-0748730419836370]; [@bibr40-0748730419836370]), elicited significant effects on the period of the circadian rhythm in RBC membrane electrophysiology, lengthening, and shortening period, respectively ([Fig. 2B](#fig2-0748730419836370){ref-type="fig"}, [C](#fig2-0748730419836370){ref-type="fig"}, [E](#fig2-0748730419836370){ref-type="fig"}). This demonstrates a role for these enzymes in the transcription-independent time-keeping mechanism of RBCs.

![Casein kinase inhibition alters the circadian rhythm of red blood cells (RBCs). (A) Immunoblots showing the expression profiles of human CK1 and CK2 paralogs in human RBCs and in human U2OS cells. Data from 2 donors are shown. U2OS cells transfected with V5-CK1α ([@bibr17-0748730419836370]), CK1δ-V5, HA-CK1ε ([@bibr41-0748730419836370]), HA-CK2α' and Myc-CK2β (both [@bibr49-0748730419836370]) served as positive controls. (B-D) Dielectrophoresis (DEP) measurements of membrane conductance (*G*~eff~) in isolated RBCs incubated at constant 37°C over 2 days in the presence of 100 nM TTP22 (CK2 inhibitor) (B), 1 μM D4476 (CK1 inhibitor) (C), or 3 μM PF-670462 (highly potent CK1 inhibitor) (D) *versus* vehicle control (mean ± SEM, *n* = 4. Extra sum-of-squares F test *p* values reported from non-linear regression comparison of fits, H~1~ = damped cosine model, H~0~ = straight line). (E) The period of *G*~eff~ rhythms are significantly affected by inhibition of CK1 and CK2 (period values derived from best fit~cosinor~ ± SEM, *n* = 4. Extra sum-of-squares F test p values reported following comparison of best fit~cosinor~. \*\**p* \< 0.01, \**p* \< 0.05).](10.1177_0748730419836370-fig2){#fig2-0748730419836370}

A lengthening of the circadian period in response to CK2 inhibition has been observed previously for other mammalian and eukaryotic models ([@bibr48-0748730419836370]). We were surprised, however, that CK1 inhibition elicited a significantly shorter circadian period in RBCs compared with controls because, to our knowledge, in all other contexts CK1 inhibition slows down the cellular clock ([@bibr1-0748730419836370]; [@bibr22-0748730419836370]; [@bibr23-0748730419836370]; [@bibr32-0748730419836370]; [@bibr51-0748730419836370]). We therefore repeated our assays using a pharmacologically distinct and highly potent inhibitor of CK1, PF-670462 ([@bibr1-0748730419836370]; [@bibr5-0748730419836370]). This resulted in a similar reduction in circadian period length as that observed with D4476 ([Fig. 2D](#fig2-0748730419836370){ref-type="fig"} and [E](#fig2-0748730419836370){ref-type="fig"}).

Temperature compensation is an evolutionarily conserved property of the circadian clock and a defining feature of bona fide circadian rhythms. CK1 and CK2 have proposed roles in temperature compensation in organisms as diverse as *Neurospora* fungi, algae and mammals ([@bibr23-0748730419836370]; [@bibr30-0748730419836370]; [@bibr47-0748730419836370]; [@bibr58-0748730419836370]). We examined the role of these cellular kinases in temperature compensation in the absence of known clock protein targets. If temperature compensation is reliant on the activity of either kinase, their inhibition will result in a Q~10~ for the period of oscillation that lies outside the temperature-compensated range of 0.8 to 1.2; i.e. inhibition of the kinase should have markedly different effects on circadian period at different temperatures. As shown in previous studies in nucleated cells ([@bibr23-0748730419836370]), inhibition of CK1 disrupted temperature compensation in (nucleated) human U2OS cells expressing a *BMAL1:Luc* reporter, with Q~10~^PF670^ = 1.60 ± 0.14 ([Fig. 3A](#fig3-0748730419836370){ref-type="fig"} and [C](#fig3-0748730419836370){ref-type="fig"}). Consistent with daily rhythms becoming temperature-dependent under CK1 inhibition, in a separate experiment, the magnitude of period lengthening due to CK1 inhibition was further reduced in U2OS cells when cultured at the higher temperature of 40°C ([Supplementary Figure S2](https://journals.sagepub.com/doi/suppl/10.1177/0748730419836370)). In contrast, CK2 inhibition had no effect on temperature compensation, i.e. Q~10~^TTP22^ (1.15 ± 0.13) was not significantly different from the vehicle Q~10~^control^ (1.02 ± 0.11, [Fig. 3C](#fig3-0748730419836370){ref-type="fig"}). In anucleate RBCs, as with U2OS cells, temperature compensation was observed both for vehicle control cultures (Q~10~^control^ = 0.94 ± 0.24) and TTP22-treated RBCs (Q~10~^TTP22^ = 0.74 ± 0.43) ([Fig. 3B](#fig3-0748730419836370){ref-type="fig"} and [D](#fig3-0748730419836370){ref-type="fig"}). Again, as with U2OS cells, CK1 inhibition abolished temperature compensation of circadian rhythms in isolated RBCs, with period lengthening at 32°C as compared with period shortening at 37°C, and a Q~10~^PF670^ of 2.60 ± 0.46 ([Fig. 3B](#fig3-0748730419836370){ref-type="fig"} and [D](#fig3-0748730419836370){ref-type="fig"}). Therefore, inhibition of CK1, but not CK2, activity abolished temperature compensation of circadian rhythms in the presence and absence of transcription-translation feedback loops ([Fig. 3C](#fig3-0748730419836370){ref-type="fig"} and [D](#fig3-0748730419836370){ref-type="fig"}).

![Temperature compensation of RBC circadian rhythms is abolished by inhibition of casein kinase 1 (CK1). (A) Nucleated human U2OS cells (*BMAL1:Luc*) were cultured at constant 32°C (top, light tone) and 37°C (bottom, full tone) following 4 days of temperature entrainment in the presence of 0.31 µM PF-670462 (CK1 inhibitor, red) or 2.5 µM TTP22 (CK2 inhibitor, blue) vs. vehicle control (black) (mean ± SEM, *n* = 6), detrended using a moving average of 24-h for vehicle and TTP22 or 30-h for PF-670462. (B) Dielectrophoretic (DEP) measurements of membrane conductance (*G*~eff~) in isolated RBCs over 2 days incubated at 32°C in the presence of 3 μM PF-670462 (light red) or 100 nM TTP22 (light blue) vs. vehicle control (mean ± SEM, *n* = 4). *P* values for DEP assays report non-linear regression comparison of fits (H~1~ = damped cosine model, H~0~ = straight line). (C and D) Inhibition of CK1 abolishes temperature compensation in U2OS (top) and RBCs (bottom). In vehicle control (black) and TTP22-treated (blue) cells, period does not change with increased temperature, reflected by a Q~10~ of approximately 1. Conversely, treatment with PF-670462 results in a significantly increased Q~10~ vs. control, reflected by the shorter period at 37°C relative to 32°C. Period values derived from best fit~cosinor~ ± SEM (n~U2OS~ = 6, n~RBC~ = 4). Holm-Sidak's multiple comparisons *p*-value reported, following one-way ANOVA (p~ANOVA~^RBC^ = 0.015, p~ANOVA~^U2OS^ = 0.017), for Q~10~ vs. vehicle. \**p \<* 0.05.](10.1177_0748730419836370-fig3){#fig3-0748730419836370}

Discussion {#section12-0748730419836370}
==========

Both CK1 and CK2 play roles in circadian period determination in many eukaryotic cellular contexts ([@bibr38-0748730419836370]). CK1 and CK2 homologs are present in RBCs (this study and [@bibr6-0748730419836370]), whereas the capacity for nascent transcription is not. Here, we have extended the timekeeping function for these ancient and ubiquitously expressed kinases to encompass regulation of circadian period in the non-transcriptional RBC clock. Whilst it is clear that PER (and other clock gene encoded) proteins are functionally relevant substrates for CK1 and CK2 in cells where cycling clock gene transcription is present, our RBC assays suggest clock protein transcription factors (TFs) are unlikely to be their only relevant substrates with respect to cellular timekeeping. Separately, this is also implied by the complete conservation of CK1 and CK2 in period determination across eukaryotes ([@bibr7-0748730419836370]; [@bibr19-0748730419836370]; [@bibr27-0748730419836370]; [@bibr31-0748730419836370]; [@bibr48-0748730419836370]; [@bibr51-0748730419836370]; [@bibr56-0748730419836370]; [@bibr57-0748730419836370]), whereas the clock protein TFs, upon which they act, are not. A parsimonious interpretation of this observation is that there exist one or more CK substrates, evolutionarily conserved but as yet unidentified, whose activity determines periodicity.

In the absence of cycling transcription and clock gene activity, we also found that the catalytic activity of CK1, but not CK2, appears to be relevant to the mechanisms that facilitate temperature compensation of RBC circadian rhythms, similar to the results of nucleated mammalian cells. In two very different human cell types, primary RBCs and the U2OS osteosarcoma cell line, inhibition of CK1 abolished temperature compensation and increased the Q~10~ for the period of oscillation. Inhibition of CK1 with PF-670462 had a greater effect on the Q~10~ of rhythms in RBCs than in U2OS cells (Q~10~ of 2.6 compared with 1.6, respectively), thus explaining the period shortening elicited by CK1 inhibition in RBCs at 37°C ([Fig. 3](#fig3-0748730419836370){ref-type="fig"} and [Supplemental Figure S2](https://journals.sagepub.com/doi/suppl/10.1177/0748730419836370)). The differential sensitivity of Q~10~ to CK1 inhibition between the two cell types may be attributable to cell type-dependent variation in the expression of CK1 isoforms; i.e., in U2OS cells, the α, δ, and ε isoforms were all readily detectable, whereas only CK1α was detected in RBCs, both in our study and in an independent mass spectrometry-based investigation ([@bibr6-0748730419836370]).

Unlike CK1δ/ε, the timekeeping functions of CK1α are less well established, being reported by two separate studies ([@bibr22-0748730419836370]; [@bibr26-0748730419836370]). Thus, an alternative interpretation of our findings is that temperature-compensated circadian rhythms in RBCs arise by a completely different mechanism from that which operates in other mammalian cell types. In this case, the similar sensitivity to CK inhibition of RBC circadian rhythms compared with other cell types, as well as their common features, such as rhythmic K^+^ transport and over-oxidised peroxiredoxin levels ([@bibr8-0748730419836370]; [@bibr13-0748730419836370]; [@bibr15-0748730419836370]; [@bibr20-0748730419836370]; [@bibr36-0748730419836370]), is simply coincidental. We note, however, that the CK1α catalytic domain shares very high sequence identity with human CK1δ/ε (78%) and CK1 orthologs in the metazoan, fungal and green lineages (\>71%), whereas the C-terminal domains that distinguish mammalian CK1 paralogs and isoforms from each other show much less conservation across the eukaryotic kingdoms. We also note that, whilst CK1ε is dispensable, CK1δ and CK1α both play essential roles in development and proliferation, possess identical substrate specificities that cannot be distinguished pharmacologically, and have many cellular targets in common ([@bibr42-0748730419836370]). Therefore, we suggest that there is very little evidence that CK1α is not equally as important as CK1δ for the regulation of circadian gene expression rhythms in mammalian cells.

Unlike most enzymes (including CK2), the activity of CK1δ/ε toward certain polypeptides is insensitive to temperature, with a Q~10~ of around 1.0 ([@bibr23-0748730419836370]; [@bibr43-0748730419836370]; [@bibr58-0748730419836370]). This temperature insensitivity is inherent to the catalytic domain of CK1, demonstrated by impaired temperature compensation of catalytic mutants against synthetic substrates compared with native sequences ([@bibr43-0748730419836370]). This "temperature-compensated domain" is conserved in other CK1δ homologs, such as human CK1α (86% similarity), including the critical lysine residue (K224 in CK1δ; K232 in CK1α). This strongly suggests that temperature compensation is a function of CK1 homologs across the eukaryotic kingdom, independent of the presence or absence of the TTFL, and functions similarly between nucleated and non-nucleated cells.

In this, we note similarities with KaiC phosphorylation in cyanobacteria, whose post-translational rhythm persists in the absence of nascent gene expression ([@bibr35-0748730419836370]; [@bibr46-0748730419836370]). Here, temperature compensation of circadian period is conferred by the intrinsically temperature-insensitive phosphotransferase activity of KaiC ([@bibr14-0748730419836370]; [@bibr45-0748730419836370]), with circadian period and temperature compensation also being sensitive to amino acid substitution around the ATP-binding site ([@bibr34-0748730419836370]; [@bibr45-0748730419836370]). Our present observations support the possibility that the role of CK1 homologs in eukaryotic circadian rhythms may be functionally analogous to that of KaiC in cyanobacteria ([@bibr33-0748730419836370]; [@bibr54-0748730419836370]).

The circadian clock regulates biological functions, such as metabolism, protein synthesis, and ion transport, in many cell types across phylogenetic kingdoms, both in the presence and absence of transcriptional feedback cycles ([@bibr8-0748730419836370]; [@bibr15-0748730419836370]; [@bibr20-0748730419836370]; [@bibr28-0748730419836370]; [@bibr37-0748730419836370]; [@bibr36-0748730419836370]; [@bibr50-0748730419836370]; [@bibr55-0748730419836370]). Though no definitive adaptive advantage has been ascribed to RBC circadian rhythms, daily variation in CO~2~-carrying potential, adverse cardiovascular events, and osmotic homeostasis are potential consequences of this reduced and highly specialised cellular clockwork ([@bibr20-0748730419836370]). Erythrocytes are the most numerous cell type in the human body. Whereas their circadian clock mechanism is not understood, it does involve the same conserved kinases that regulate timekeeping fidelity in other mammalian cell types. Future studies should identify which RBC proteins might be subject to circadian post-translational modification by CK1 and CK2, and whether these also exhibit phosphorylation rhythms in other cell types.
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